Seretide

Seretide Description

salmeterol + fluticasone

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Accuhaler: Moulded plastic device containing a foil strip with 60 regularly placed blisters each containing 50 micrograms of salmeterol as salmeterol xinafoate and 100, 250 or 500 micrograms of fluticasone propionate.
Evohaler: Each single actuation of SERETIDE provides: Salmeterol xinafoate equivalent to 25 micrograms salmeterol and 50, 125 or 250 micrograms of fluticasone propionate.
Seretide Evohaler comprises a suspension of salmeterol and fluticasone propionate in the non-CFC propellant HFA 134a. The suspension is contained in an aluminium alloy can sealed with a metering valve. The canisters are fitted into plastic actuators incorporating an atomising orifice and fitted with dust caps.
The canister has a dose counter attached to it, which shows how many actuations of medicine are left. The number will show through a window in the back of the plastic actuator. SERETIDE Evohaler has been formulated in three strengths and one pack sizes, delivering 120 actuations per inhaler.
Excipients/Inacctive Ingredients: Accuhaler: Lactose (which contains milk protein).
Evohaler: HFA 134a.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in